Semler Scientific, Inc. (NASDAQ:SMLR) Shares Purchased by Legal & General Group Plc

Legal & General Group Plc increased its holdings in Semler Scientific, Inc. (NASDAQ:SMLR) by 65.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,056 shares of the company’s stock after purchasing an additional 813 shares during the quarter. Legal & General Group Plc’s holdings in Semler Scientific were worth $111,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of SMLR. Invesco Ltd. purchased a new position in shares of Semler Scientific during the 4th quarter valued at approximately $5,964,000. Thames Capital Management LLC acquired a new position in Semler Scientific during the fourth quarter worth $6,465,000. Wells Fargo & Company MN grew its position in shares of Semler Scientific by 618.3% in the fourth quarter. Wells Fargo & Company MN now owns 103,465 shares of the company’s stock valued at $5,587,000 after purchasing an additional 89,060 shares during the period. Geode Capital Management LLC increased its stake in shares of Semler Scientific by 3.3% during the fourth quarter. Geode Capital Management LLC now owns 140,423 shares of the company’s stock worth $7,584,000 after purchasing an additional 4,464 shares in the last quarter. Finally, Level Four Advisory Services LLC purchased a new stake in shares of Semler Scientific during the fourth quarter worth about $640,000. 49.37% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Lake Street Capital lifted their price objective on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.

Semler Scientific Stock Performance

NASDAQ SMLR opened at $33.33 on Friday. The business has a fifty day moving average price of $35.88 and a 200 day moving average price of $46.16. The company has a market cap of $319.87 million, a P/E ratio of 6.79 and a beta of 1.29. Semler Scientific, Inc. has a one year low of $20.88 and a one year high of $81.56.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million during the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.